Harvard Bioscience (HBIO) EBITDA Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 722.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 205.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -2,360.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 612.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -368.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -1,189.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -1,384.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 799.00 |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -707.00 |
| Mar 31, 2026 | -1,149.00 |
| Dec 31, 2025 | 881.00 |
| Sep 30, 2025 | 1,493.00 |
| Jun 30, 2025 | -1,769.00 |
| Mar 31, 2025 | -20,478.00 |
| Dec 31, 2024 | -510.00 |
| Sep 30, 2024 | -1,038.00 |
| Jun 30, 2024 | -916.00 |
| Mar 31, 2024 | -841.00 |
| Dec 31, 2023 | -789.00 |
| Sep 30, 2023 | -444.00 |
| Jun 30, 2023 | 38.00 |
| Mar 31, 2023 | 1,960.00 |
| Dec 31, 2022 | -688.00 |
| Sep 30, 2022 | -900.00 |
| Jun 30, 2022 | 1,292.00 |
| Mar 31, 2022 | -2,290.00 |
| Dec 31, 2021 | -1.00 |
| Sep 30, 2021 | -126.00 |